false
0000764630
0000764630
2026-09-21
2026-09-21
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): September 21, 2026
AETERNUM
HEALTH, INC.
(Exact
name of registrant as specified in our charter)
| Delaware |
|
001-15913 |
|
06-1120072 |
(State
of other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
601
Pennsylvania Avenue, NW, South Building, Suite 900,
Washington,
DC |
|
20004 |
| (Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (202) 580-6500
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $.01 |
|
AETN |
|
OTC
ID |
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01 Entry into a Material Definitive Agreement.
On
September 21, 2026, the registrant, Aeternum Health, Inc. (“Aeternum” or the “Company”), in connection with
its entry to the mining and production of critical minerals, acquired from American Renaissance Resources LLC, (“ARR”)
under the terms of a Membership Interest Purchase Agreement dated September 21, 2026 (the “Agreement”), all the
membership interests that American Renaissance Resources LLC owned in American Renaissance Minerals LLC (“ARM”) for
which the Company has agreed to issue up to 133,333,333 pre-split shares of its common stock or, if required by the terms of a
beneficial ownership limitation contained in the Agreement, pre-funded warrants to purchase shares of common stock of the Company,
in stages against project milestones. ARM has the right to acquire the Nkamouna Nickel-Cobalt mining project in Cameroon. The
Agreement also includes an exhibit for the Investor Rights Agreement between the Company and ARR under which the Company grants observer right to ARR to participate in the Company’s Board meetings with
standard rights of exclusion, such as being able to exclude ARR for purposes of protecting the attorney-client privilege, and to register
for sale of ARR’s “ Registrable Securities” defined collectively as the Closing Shares, the Contingent Shares and the
Common Stock (as those capitalized terms are defined in the Investor Rights Agreement) issuable on exercise of the Pre-Funded Warrants
that are held by or potentially issuable to ARR. ARR only receives the observer rights and registration rights if it holds over 9.9% of
the Company’s Registrable Securities that it acknowledges it currently does not own, and should it in the future hold over 9.9%
of Registrable Securities, the observer rights terminate on the earliest to occur of (i) the date that is fifteen (15) months after the
date of the Investor Rights Agreement where the ARR Ownership Percentage is not then greater than 9.9%, or (ii) the first day thereafter
when the ARR Ownership Percentage ceases to exceed 9.9% and, with respect to the registration rights, upon the earliest to occur of (i)
the first day on which ARR ceases to hold any Registrable Securities or Pre-Funded Warrants, or (ii) the first day on which all of the
Registrable Securities held by ARR and issuable upon exercise of Pre-Funded Warrants held by ARR may be resold pursuant to Rule 144 without
any volume limitations. The foregoing descriptions of the Agreement and the Investor Rights Agreement do not purport to be
complete and are qualified in their entirety by reference to the full text of both agreements that are attached as Exhibit 10.1
and 10.2, respectively, hereto and incorporated herein by reference.
Item
3.02. Unregistered Sales of Equity Securities.
The
matters described in Item 1.01 of this Current Report on Form 8-K are incorporated herein by reference.
Item
7.01 Regulation FD Disclosures.
On
September 25, 2026, the Company issued a press release regarding the purchase of the membership interests of ARM described in Item 1.01
of this Current Report on Form 8-K. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.
In
accordance with General Instruction B.2 of this Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1,
shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing
under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing.
Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination
by Laser Photonics that the information contained herein, including the exhibits hereto, is material or that the dissemination of such
information is required by Regulation FD.
Item
9.01 Financial Statements and Exhibits.
| |
Exhibits |
|
| |
|
|
| |
10.1 |
Membership Interest Purchase Agreement dated September 21, 2026, between Aeternum Health, Inc. and American Renaissance Resources LLC |
| |
|
|
| |
10.2 |
Investor Rights Agreement dated September 21, 2026, between Aeternum Health, Inc. and American Renaissance Resources LLC |
| |
|
|
| |
99.1 |
Press Release issued September 25, 2026 |
| |
|
|
| |
104 |
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this Form 10 to be signed on
our behalf by the undersigned, thereunto duly authorized.
| Date:
September 25, 2026 |
AETERNUM
HEALTH, INC. |
| |
|
| |
By: |
/s/
Paul Mann |
| |
Name: |
Paul
Mann |
| |
Title: |
President |
Exhibit 99.1

Aeternum
Resources Announces Agreement to Acquire 100% of American Renaissance Minerals, Sponsor of the Nkamouna Cobalt-Nickel-Manganese Project
in Cameroon
| ● | American
Renaissance Minerals, a company focused on advancing the Nkamouna Cobalt-Nickel-Manganese
Project in Cameroon, is working with the Government of Cameroon toward the award of a new
mining permit over the project, free of prior encumbrance. |
| ● | The
transaction consolidates into a single company the joint venture announced on August 7, 2026,
under which Aeternum Resources held an option over a 51% interest in American Renaissance
Minerals. On closing, Aeternum Resources will own the whole of American Renaissance Minerals
and the underlying option arrangements will be terminated. |
| ● | Nickel
and cobalt are both designated critical minerals by the United States, which imports approximately
three quarters of the cobalt it consumes and, excluding recycled material, is almost wholly
reliant on imports for its nickel supply. |
Washington
D.C. – September 22, 2026 — Aeternum (OTC: AETN) (“Company”), a company aiming to become a highly strategic
supplier of critical minerals, today announced that it has entered into an agreement dated September 16, 2026 to acquire all of the issued
and outstanding membership interests in American Renaissance Minerals LLC (“ARM”) from ARM’s shareholder. ARM is the
dedicated project vehicle seeking to advance the Nkamouna Cobalt-Nickel-Manganese Project in Cameroon. The transaction is subject to
customary conditions and is expected to close in the fourth quarter of 2026.
On
August 7, 2026, the Company announced that it had acquired an option to acquire a 51% interest in ARM. The transaction announced today
replaces that arrangement with direct ownership of the whole of ARM, and the investment agreement under which the option arose will be
terminated at or before closing. The Company believes that a single corporate owner simplifies the ownership of the project ahead of
the possible award of a new mining permit.
Subject
to the terms and conditions of the agreement, the Company has agreed to issue up to 133,333,333 shares of common stock of the Company
or, if required by the terms of a beneficial ownership limitation contained in the agreement, pre-funded warrants to purchase shares
of common stock of the Company, in stages against project milestones. The figures expressed above are expressed prior to giving effect
to the Company’s previously announced 1-for-20 reverse stock split, and are subject to adjustment for the reverse stock split and
any other similar transactions. ARM’s shareholder will continue to support the project’s United States Government financing
engagement, and the Company and ARM’s shareholder intend to cooperate on future opportunities.
Nkamouna
is one of the largest undeveloped cobalt-nickel-manganese projects globally. The project was fully permitted between 2003 and 2025 by
its prior operator, and the permit was withdrawn in February 2025. ARM currently holds certain historical data regarding the property,
and is working with the Government of Cameroon, including the Ministry of Mines, Industry and Technological Development and the Société
Nationale des Mines, toward the award of a new mining permit, free of prior encumbrance. If a mining permit is granted, the project will
be developed in accordance with Cameroon’s Mining Code of December 2023, including the 10% free-carried interest of the State,
with a concentrator at the mine site producing an exportable concentrate rather than shipping unprocessed ore, so that the first stage
of processing and its associated value are retained in Cameroon.
Upon
ownership of the title, the Company intends to approach the project with urgency. Concept engineering for the concentrator draws directly
on the modular gravity-separation plant the Company is currently constructing in Nigeria, and the Company’s own engineering and
construction team has designed, manufactured and installed comparable plant in Africa within the past year.
“We
are taking full ownership because we intend to build this mine, and to build it quickly,” said Josua Oosthuizen, Chief Executive
Officer of Aeternum Resources. “Our team has spent the past year designing, manufacturing and installing a gravity separation
plant for our Nigerian project. That is the same engineering, the same discipline and in large part the same people we would put on Nkamouna.
We are ready to move as soon as there is a permit to work against.”
ABOUT
AETERNUM
Aeternum
(OTC: AETN) seeks to become a highly strategic supplier of critical minerals. Its first resource is a mine located in the Jos Plateau
in Nigeria that will focus on the production of tin, niobium, tantalum and other metals.
Led
by a management team with a track record of designing, building and commissioning mineral-processing plants in Africa, and supported
by independent geological and metallurgical consultants, Aeternum’s goal is to develop multiple assets globally and create a diversified
revenue stream from several critical minerals
FORWARD
LOOKING STATEMENTS
This
press release contains forward-looking statements that are subject to various risks and uncertainties. These forward-looking statements
include statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,”
“anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,”
“potential,” or other similar expressions, and include statements regarding the expected closing of the transaction, the satisfaction
of the conditions to closing, the expected termination of previous agreements, the award of a new mining permit, the issuance of contingent
consideration, minerals anticipated to be encountered on a project, and future government engagement, opportunities, construction, development,
production and revenue from current and proposed projects. Although the Company believes that the expectations expressed in these forward-looking
statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors
that actual results may differ materially from the anticipated results. Such factors include, among others, risks that the conditions
to closing are not satisfied and that the transaction does not complete; risks relating to the timing and ability of the Company to obtain,
and the timing of the approval of, relevant regulatory bodies, if at all; risks relating to the need for additional capital to complete
development and commence production on any of the Company’s projects; property interests; risks related to access to the project;
risks inherent in mineral exploration, including the fact that any particular phase of exploration may be unsuccessful; the availability
of contractors; geo-political risks; the global economic climate; metal prices; environmental risks; political risks; community and non-governmental
actions; and the other risks identified in the Company’s filings with the Securities and Exchange Commission, which are available
at www.sec.gov. Geological similarities or characteristics are not guarantees or certainties of successful exploration. The Company does
not undertake, and assumes no obligation, to update or revise any such forward-looking statements or forward-looking information contained
herein to reflect new events or circumstances, except as may be required by law.
For
more information, please contact:
Aeternum
Investor
Relations Department
Email:
info@aeternumresources.com